{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:15:51Z","timestamp":1789103751326,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.aohep.2024.101495","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T17:59:03Z","timestamp":1709834343000},"page":"101495","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy and safety of terlipressin and albumin vs. noradrenaline and albumin in adult patients with hepatorenal syndrome: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4276-205X","authenticated-orcid":false,"given":"Adnan","family":"Malik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Imran","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahbaz","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Nadir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.aohep.2024.101495_bib0001","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.510230122","article-title":"Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club","volume":"23","author":"Arroyo","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2024.101495_bib0002","first-page":"13","article-title":"Norepinephrine versus terlipressin in patients with type 1 hepatorenal syndrome refractory to treatment with octreotide, midodrine, and albumin: a prospective randomized comparative study","volume":"7","author":"Badawy","year":"2013","journal-title":"Egypt J Cardiothorac Anesth"},{"issue":"2","key":"10.1016\/j.aohep.2024.101495_bib0003","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/hep.31884","article-title":"Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the american association for the study of liver diseases","volume":"74","author":"Biggins","year":"2021","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.aohep.2024.101495_bib0004","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.amjmed.2015.12.006","article-title":"Preventing and treating acute kidney injury among hospitalized patients with cirrhosis and ascites: a narrative review","volume":"129","author":"Tapper","year":"2016","journal-title":"Am J Med"},{"issue":"998","key":"10.1016\/j.aohep.2024.101495_bib0005","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/gut.2006.107789","article-title":"Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis","volume":"84","author":"Salerno","year":"2008","journal-title":"Postgrad Med J"},{"issue":"6","key":"10.1016\/j.aohep.2024.101495_bib0006","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/hep.20687","article-title":"MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation","volume":"41","author":"Alessandria","year":"2005","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.aohep.2024.101495_bib0007","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1046\/j.1440-1746.2003.02934.x","article-title":"Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial","volume":"18","author":"Solanki","year":"2003","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.aohep.2024.101495_bib0008","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/00365520510012064","article-title":"Pathophysiological basis of pharmacotherapy in the hepatorenal syndrome","volume":"40","author":"Moller","year":"2005","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"10.1016\/j.aohep.2024.101495_bib0009","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1572-0241.2005.40952.x","article-title":"Hepatorenal syndrome: a dreaded complication of end-stage liver disease","volume":"100","author":"C\u00e1rdenas","year":"2005","journal-title":"J Am College Gastroenterol"},{"issue":"4","key":"10.1016\/j.aohep.2024.101495_bib0010","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2007.04.010","article-title":"Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study","volume":"47","author":"Alessandria","year":"2007","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.aohep.2024.101495_bib0011","first-page":"30","article-title":"Noradrenaline is as effective as terlipressin in hepatorenal syndrome type 1: a prospective, randomized trial","volume":"64","author":"Goyal","year":"2016","journal-title":"J Assoc Physician India"},{"issue":"7","key":"10.1016\/j.aohep.2024.101495_bib0012","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/j.1572-0241.2008.01828.x","article-title":"An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response","volume":"103","author":"Sharma","year":"2008","journal-title":"J Am College Gastroenterol"},{"key":"10.1016\/j.aohep.2024.101495_bib0013","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s11739-016-1478-7","article-title":"Emerging hepatic syndromes: pathophysiology, diagnosis and treatment","volume":"11","author":"Bertino","year":"2016","journal-title":"Intern Emerg Med"},{"issue":"4","key":"10.1016\/j.aohep.2024.101495_bib0014","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005162.pub2","article-title":"Terlipressin for hepatorenal syndrome","author":"Gluud","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.aohep.2024.101495_bib0015","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11255-010-9725-8","article-title":"Terlipressin in hepatorenal syndrome: a systematic review and meta-analysis","volume":"43","author":"Dobre","year":"2011","journal-title":"Int Urol Nephrol"},{"issue":"5","key":"10.1016\/j.aohep.2024.101495_bib0016","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/j.1440-1746.2009.06132.x","article-title":"Terlipressin therapy for reversal of type 1 hepatorenal syndrome: a meta-analysis of randomized controlled trials","volume":"25","author":"Sagi","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.aohep.2024.101495_bib0017","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.gtc.2011.06.011","article-title":"Hepatorenal syndrome: do the vasoconstrictors work?","volume":"40","author":"Leung","year":"2011","journal-title":"Gastroenterol Clin"},{"issue":"8","key":"10.1016\/j.aohep.2024.101495_bib0018","first-page":"1733","article-title":"Hepatology committee of chinese research hospital a. practice guidance for the use of terlipressin for liver cirrhosis related complications (2021)","volume":"38","year":"2022","journal-title":"\u4e34\u5e8a\u809d\u80c6\u75c5\u6742\u5fd7"},{"issue":"11","key":"10.1016\/j.aohep.2024.101495_bib0019","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1080\/17474124.2017.1356223","article-title":"Comparative efficacy of vasoconstrictor therapies for type 1 hepatorenal syndrome: a network meta-analysis","volume":"11","author":"Zheng","year":"2017","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.aohep.2024.101495_bib0020","doi-asserted-by":"crossref","first-page":"172","DOI":"10.14306\/renhyd.18.3.114","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"18","author":"Moher","year":"2014","journal-title":"Revista Espanola de Nutricion Humana y Dietetica"},{"key":"10.1016\/j.aohep.2024.101495_bib0021","doi-asserted-by":"crossref","unstructured":"Julian P.T.Higgins JT, Jacqueline Chandler, Miranda Cumpston, Tianjing Li, Matthew J. Page, Vivian A. Welch. Cochrane Handbook for Systematic Reviews of Interventions. 2019. https:\/\/doi.org\/10.1002\/9781119536604.","DOI":"10.1002\/9781119536604"},{"key":"10.1016\/j.aohep.2024.101495_bib0022","first-page":"2010","article-title":"Style (DeKalb, IL)","author":"Microsoft Excel","year":"2010","journal-title":"Microsoft"},{"issue":"3","key":"10.1016\/j.aohep.2024.101495_bib0023","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/10503307.2017.1411628","article-title":"Cochrane's risk of bias tool in the context of psychotherapy outcome research","volume":"28","author":"Munder","year":"2018","journal-title":"Psychother Res"},{"key":"10.1016\/j.aohep.2024.101495_bib0024","unstructured":"F.L. Endnote. Aperture; 2021."},{"issue":"8","key":"10.1016\/j.aohep.2024.101495_bib0025","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/liv.12179","article-title":"Noradrenaline vs terlipressin in the treatment of type 2 hepatorenal syndrome: a randomized pilot study","volume":"33","author":"Ghosh","year":"2013","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.aohep.2024.101495_bib0026","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/hep.30208","article-title":"Terlipressin is superior to noradrenaline in the management of acute kidney injury in acute on chronic liver failure","volume":"71","author":"Arora","year":"2020","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.aohep.2024.101495_bib0027","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jhep.2012.01.012","article-title":"Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: a randomized study","volume":"56","author":"Singh","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2024.101495_bib0028","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s12664-018-0876-3","article-title":"Noradrenaline versus terlipressin in the management of type 1 hepatorenal syndrome: a randomized controlled study","volume":"37","author":"Saif","year":"2018","journal-title":"Indian J Gastroenterol"},{"issue":"1","key":"10.1016\/j.aohep.2024.101495_bib0029","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1016\/j.jceh.2013.02.242","article-title":"Noradrenaline is equally effective as terlipressin in reversal of type 1 hepatorenal syndrome: a randomized prospective study","volume":"3","author":"Indrabi","year":"2013","journal-title":"J Clin Exp Hepatol"},{"issue":"4","key":"10.1016\/j.aohep.2024.101495_bib0030","first-page":"220","article-title":"Hyponatremia and hepatorenal syndrome","volume":"11","author":"Mohanty","year":"2015","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"4","key":"10.1016\/j.aohep.2024.101495_bib0031","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/0885066614566794","article-title":"Hyponatremia: a review","volume":"31","author":"Buffington","year":"2016","journal-title":"J Intensive Care Med"},{"issue":"5","key":"10.1016\/j.aohep.2024.101495_bib0032","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s10620-019-05858-2","article-title":"Limited progress in hepatorenal syndrome (HRS) reversal and survival 2002\u20132018: a systematic review and meta-analysis","volume":"65","author":"Thomson","year":"2020","journal-title":"Dig Dis Sci"},{"issue":"9","key":"10.1016\/j.aohep.2024.101495_bib0033","article-title":"Terlipressin versus other vasoactive drugs for hepatorenal syndrome","volume":"9","author":"Israelsen","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.aohep.2024.101495_bib0034","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa2008290","article-title":"Terlipressin plus albumin for the treatment of type 1 hepatorenal syndrome","volume":"384","author":"Wong","year":"2021","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.aohep.2024.101495_bib0035","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/gastro\/goz043","article-title":"Pharmacological treatment of hepatorenal syndrome: a network meta-analysis","volume":"8","author":"Wang","year":"2020","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"2","key":"10.1016\/j.aohep.2024.101495_bib0036","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S2468-1253(16)30157-1","article-title":"Comparative efficacy of pharmacological strategies for management of type 1 hepatorenal syndrome: a systematic review and network meta-analysis","volume":"2","author":"Facciorusso","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.aohep.2024.101495_bib0037","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MEG.0000000000000537","article-title":"Terlipressin versus noradrenaline in the treatment of hepatorenal syndrome: systematic review with meta-analysis and full economic evaluation","volume":"28","author":"de Mattos","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.aohep.2024.101495_bib0038","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jhep.2012.01.012","article-title":"Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: a randomized study","volume":"56","author":"Singh","year":"2012","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.aohep.2024.101495_bib0039","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S2468-1253(16)30157-1","article-title":"Comparative efficacy of pharmacological strategies for management of type 1 hepatorenal syndrome: a systematic review and network meta-analysis","volume":"2","author":"Facciorusso","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268124002898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268124002898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T23:45:21Z","timestamp":1719531921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268124002898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1665268124002898"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2024.101495","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of terlipressin and albumin vs. noradrenaline and albumin in adult patients with hepatorenal syndrome: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2024.101495","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"101495"}}